Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson’s disease

29 Jul 2022

Abstract excerpt

Together with neuronal loss, the existence of insoluble inclusions of alpha-synuclein (α-syn) in the brain is widely accepted as a hallmark of synucleinopathies including Parkinson's disease (PD), multiple system atrophy, and dementia with Lewy body. Because the α-syn aggregates are deeply involved in the pathogenesis, there have been many attempts to demonstrate the mechanism of the aggregation and its potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Botulinum Toxin and Related Neurological Disorders
Share to Neurological disorders and treatments
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35733294
DOI: 10.5483/bmbrep.2022.55.7.073

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson’s diseasePMID 35733294Read ↗

The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s DiseasesSemantic proximity Read ↗

Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body DisordersSemantic proximity Read ↗

Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s DiseaseSemantic proximity Read ↗

⍺-Synuclein levels in Parkinson's disease – Cell types and forms that contribute to pathogenesisSemantic proximity Read ↗

Protein modification in neurodegenerative diseasesSemantic proximity Read ↗

Alpha-Synuclein Aggregation in Parkinson's DiseaseSemantic proximity Read ↗

Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.Semantic proximity Read ↗

Alpha-Synuclein Aggregation and Spread: Implications for the Pathology and Progression of Neurodegenerative DiseasesSemantic proximity Read ↗

Navigating the Neurobiology of Parkinson’s: The Impact and Potential of α-SynucleinSemantic proximity Read ↗

Alpha-Synuclein Posttranslational Modification and Alternative Splicing as a Trigger for NeurodegenerationSemantic proximity Read ↗

Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in NeurodegenerationSemantic proximity Read ↗

Alpha-Synuclein in Neurodegeneration: From Shared Biology to Disease-Specific Phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.